Dettol maker Reckitt Benckiser’s sales slow as it warns over prices

Consumer goods group, which also makes Nurofen and Durex, says its costs are rising

Consumer goods group Reckitt Benckiser, which owns brands including Dettol, Nurofen and Durex, has warned it will be forced to increase its prices later this year to deal with rising raw material costs.

Sounding the alarm in a downbeat stock market update, the Slough-based company said the price rises will come through in the second half of the year when it will also work to improve its productivity.

It comes as the firm faces mounting inflationary pressure in its supply chain alongside a squeeze on profit margins, amid concern over the impact from Covid and Brexit disruption to international supply chains and shortages of key raw materials.

Against a backdrop of supply chain bottlenecks and rising demand for goods and services as Britain emerges from lockdown, consumer prices have jumped in recent months. Although the Bank of England expects the recent inflationary burst will prove temporary as Covid disruption recedes, some economists warn that the cost of living has further to rise as manufacturers and retailers battle a squeeze on their profits margins.

Shares in Reckitt fell by 8% on Tuesday, making them the biggest faller on London’s FTSE 100, after the company said rising costs had pushed its operating profit for the first six months of the year down by 5% to £1.4bn.

Laxman Narasimhan, the firm’s chief executive, said it was facing between 8% and 9% rises in the cost of commodities, which he described as “historically, some of the highest inflation we have seen in a short period of time”.

“It’s coming pretty much across the board, but in particular oils, surfactants, logistics, freight, for example, are clear areas that we have highlighted,” Narasimhan said.

He said the company would work out how the rising costs would feed through to price increases for its products on a country-by-country basis.

“This is a local market-by-market decision. You can look at where you stand versus competitors, look at what we can afford, we don’t want to lose competitiveness and so you’ll end up making that call literally market-by-market.

“We expect that we won’t be able to offset all commodity inflation by the end of this year, but we hope to do so by next year,” he said.

The warning comes just days after rival consumer goods group Unilever said a rise in the price of toiletries, cleaning products and salad dressings was on the way, after the biggest surge in raw material costs in a decade.

The maker of brands including Dove shampoo, Domestos bleach and Hellmann’s mayonnaise said a big jump in the price of commodities such as crude, palm and soya bean oil, coupled with higher transport and packaging costs, was hitting its profitability.

“For years, the market has assumed that big consumer goods companies had such strong brands that it was easy to pass on any extra costs to the customer in the form of higher prices. Unilever recently showed that wasn’t quite the case, and now Reckitt has also poured cold water on that theory,” said Danni Hewson, a financial analyst at the City stockbroker AJ Bell.

Sign up to the daily Business Today email or follow Guardian Business on Twitter at @BusinessDesk

“With consumers increasingly flocking to cheaper supermarket own-label products, the idea that the big brand owners are guaranteed sales success is no longer a given,” she said.

Reckitt expects consumers’ urge to clean to outlast Covid-19. Its disinfectant brands Dettol and Lysol are selling 80% more than they were in the first half of 2019, accounting for about a quarter of the company’s net revenue, compared with 16% before the pandemic.

Excluding its Chinese baby formula business, which is currently for sale, Reckitt’s like-for-like net revenue for the first half of the year reached £6.3bn, an annual rise of 3.7%.

Contributor

Joanna Partridge

The GuardianTramp

Related Content

Article image
Boss of Dettol maker Reckitt Benckiser unexpectedly resigns
Laxman Narasimhan surprises investors by saying he will leave for US halfway through turnaround plan

Jasper Jolly

01, Sep, 2022 @11:11 AM

Article image
Double-digit price hikes help Heinz and Reckitt post jump in value sales
Dettol maker says customers willing to accept increases on branded items, and that further rises on the way

Sarah Butler

27, Jul, 2022 @3:48 PM

Article image
Reckitt Benckiser to pay $1.4bn fine over opioid treatment sales
Nurofen maker reaches deal with US over alleged fraudulent marketing of Suboxone

Sean Farrell

11, Jul, 2019 @8:36 AM

Article image
KitKat to Dettol: UK consumers warned of further price hikes
Nestlé joins other firms in passing on rising costs, adding to financial squeeze facing UK households

Joanna Partridge

17, Feb, 2022 @3:33 PM

Article image
Durex sales surge after end of UK national Covid lockdown
Reckitt Benckiser says condom sales rose more than 10% after restrictions were relaxed

Zoe Wood

20, Oct, 2020 @11:39 AM

Article image
Reckitt Benckiser's $1.4bn settlement over Suboxone verges on the farcical | Nils Pratley
The UK company may have avoided a day in court, but its claims of innocence will never be tested

Nils Pratley

11, Jul, 2019 @6:57 PM

Article image
Reckitt Benckiser paid chief executive more than £23m last year
Rakesh Kapoor’s pay package almost doubled in 2015 because of a share-based bonus linked to company performance

Rob Davies

04, Apr, 2016 @12:37 PM

Article image
Reckitt Benckiser upbeat despite emerging markets sales slowdown

Maker of brands including Dettol and Nurofen expects revenues to rise as firm increases sales of its 19 'powerbrands'

Sean Farrell

12, Feb, 2014 @1:44 PM

Article image
Post-lockdown colds spur sales at Strepsils and Nurofen maker
Reckitt Benckiser records better than expected results after rise in cases of coughs and flu

Rupert Neate

26, Oct, 2021 @3:04 PM

Article image
CEO of firm behind Dettol and Durex has pay cut by £11m
Reckitt Benckiser chief Rakesh Kapoor sees pay slashed to £12.5m after share price slump

Rob Davies

28, Mar, 2018 @4:19 PM